Anebulo Pharmaceuticals Board Approves Reverse Stock Split
I'm PortAI, I can summarize articles.
Anebulo Pharmaceuticals Inc. announced its Board's approval of a proposed reverse stock split of common stock, pending stockholder approval at a future special meeting. The meeting date is yet to be determined, and the Board is reviewing strategic alternatives. This AI-generated news is for informational purposes and not financial advice. Original content was published via EDGAR by Anebulo Pharmaceuticals.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments